Pharmacokinetics and Variability of Irinotecan Treatment

This chapter offers a comprehensive overview of irinotecan, examining its role in treating various cancers and its pharmacokinetic profile. It highlights how genetic factors, particularly UGT1A1 variations, affect treatment efficacy and the side effects experienced by patients.